# Tunneled Pleural Catheters for Refractory Effusions Attributed to Congestive Heart Failure (TREAT-CHF) Trial

> **NCT03696524** · NA · WITHDRAWN · sponsor: **University of California, Los Angeles**

## Conditions studied

- Pleural Effusions, Chronic
- Congestive Heart Failure
- Shortness of Breath

## Interventions

- **DEVICE:** tunneled pleural catheter

## Key facts

- **NCT ID:** NCT03696524
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-10-01
- **Primary completion:** 2024-10-01
- **Final completion:** 2025-10-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of enrollment
- **Last updated:** 2023-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03696524

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03696524, "Tunneled Pleural Catheters for Refractory Effusions Attributed to Congestive Heart Failure (TREAT-CHF) Trial". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT03696524. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*